{"id":"W4285261941","doi":"10.1177/20363613221100033","title":"Quality of life of patients with soft tissue sarcoma treated with doxorubicin in the ANNOUNCE phase III clinical trial","year":2022,"lang":"en","type":"article","venue":"Rare Tumors","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Eli Lilly and Company","keywords":"Medicine; Soft tissue sarcoma; Doxorubicin; Clinical trial; Soft tissue; Quality of life (healthcare); Sarcoma; Phases of clinical research; Internal medicine; Oncology; Surgery; Pathology; Chemotherapy; Nursing","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002669542,0.0007143302,0.001358432,0.0001780466,0.0002144264,0.0006640197,0.0003505676,0.0004592606,0.002666939],"category_scores_gemma":[0.001816394,0.000223069,0.001446615,0.0003009269,0.0003889025,0.000383213,0.0004487947,0.001314281,0.0003407754],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004310733,"about_ca_system_score_gemma":0.0008712162,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002089781,"about_ca_topic_score_gemma":0.0006517385,"domain_scores_codex":[0.9990791,0.0005610149,0.00007628986,0.00009768366,0.000115155,0.00007063791],"domain_scores_gemma":[0.9989182,0.0002388837,0.0004860694,0.00008524469,0.00007596976,0.0001956762],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9118531,0.007306966,0.03178541,0.001167947,0.002830577,0.00006949844,0.0000872867,0.00145495,0.00473248,0.0002406597,0.003738277,0.03473282],"study_design_scores_gemma":[0.5594766,0.2919089,0.1332038,0.000203356,0.003568385,0.0003028194,0.0001026929,0.001723291,0.002298851,0.0003856963,0.006772636,0.00005299492],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9913934,0.00293949,0.0003316519,0.0004028488,0.0001053643,0.0009741397,0.001896884,0.00003049162,0.00192561],"genre_scores_gemma":[0.9902227,0.001543565,0.0006495713,0.000455188,0.0001768145,0.00201243,0.004097237,0.000009599318,0.0008329655],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002669542,"threshold_uncertainty_score":0.01411808,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05644244604112402,"score_gpt":0.3660293904129465,"score_spread":0.3095869443718224,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}